We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-18.37%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$117M
AUM Growth
-$32.1M
Cap. Flow
-$3.56M
Cap. Flow %
-3.04%
Top 10 Hldgs %
26.79%
Holding
177
New
26
Increased
45
Reduced
40
Closed
44

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$1.3M
2
GILD icon
Gilead Sciences
GILD
+$1.2M
3
ATVI
Activision Blizzard
ATVI
+$1.18M
4
PB icon
Prosperity Bancshares
PB
+$1.08M
5
RTX icon
RTX Corp
RTX
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 23.26%
2 Technology 17.65%
3 Consumer Staples 17.28%
4 Industrials 13.42%
5 Financials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
1
Church & Dwight Co
CHD
$23.4B
$4.75M 4.05%
73,975
-2,700
-4% -$192K
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$4.58M 3.91%
34,889
+1,775
+5% +$252K
CSCO icon
3
Cisco
CSCO
$457B
$3.93M 3.36%
100,050
+11,500
+13% +$505K
INTC icon
4
Intel
INTC
$455B
$2.91M 2.48%
53,727
-4,685
-8% -$277K
AAPL icon
5
Apple
AAPL
$4.54T
$2.81M 2.4%
44,236
KMB icon
6
Kimberly-Clark
KMB
$36.3B
$2.66M 2.27%
20,788
WASH icon
7
Washington Trust Bancorp
WASH
$743M
$2.6M 2.22%
71,048
DIS icon
8
Walt Disney
DIS
$167B
$2.5M 2.13%
25,835
+3,880
+18% +$491K
KO icon
9
Coca-Cola
KO
$377B
$2.33M 1.99%
52,625
+11,300
+27% +$610K
MSFT icon
10
Microsoft
MSFT
$3.45T
$2.32M 1.98%
14,709
-25
-0.2% -$4.11K
UPS icon
11
United Parcel Service
UPS
$88.6B
$2.19M 1.87%
23,475
+3,325
+17% +$344K
PFE icon
12
Pfizer
PFE
$143B
$2.12M 1.81%
68,309
+10,224
+18% +$348K
ABT icon
13
Abbott
ABT
$183B
$2.1M 1.79%
26,553
+1,400
+6% +$117K
ZTS icon
14
Zoetis
ZTS
$32.4B
$2.08M 1.77%
17,648
+175
+1% +$23K
MRK icon
15
Merck
MRK
$322B
$2.02M 1.72%
27,479
+3,249
+13% +$255K
BMY icon
16
Bristol-Myers Squibb
BMY
$133B
$1.97M 1.68%
35,337
+4,300
+14% +$263K
CSX icon
17
CSX Corp
CSX
$93.4B
$1.84M 1.57%
96,225
+5,700
+6% +$133K
CVS icon
18
CVS Health
CVS
$133B
$1.55M 1.33%
26,200
+2,316
+10% +$155K
PG icon
19
Procter & Gamble
PG
$336B
$1.49M 1.27%
13,501
-25
-0.2% -$3K
PEP icon
20
PepsiCo
PEP
$190B
$1.48M 1.27%
12,338
+6,400
+108% +$865K
UNP icon
21
Union Pacific
UNP
$174B
$1.42M 1.21%
10,049
+6,100
+154% +$1.01M
TSN icon
22
Tyson Foods
TSN
$20.4B
$1.36M 1.16%
23,450
+9,350
+66% +$699K
NKE icon
23
Nike
NKE
$61.9B
$1.32M 1.13%
15,985
+1,050
+7% +$97.7K
GIS icon
24
General Mills
GIS
$19.1B
$1.31M 1.12%
24,925
+11,400
+84% +$602K
VZ icon
25
Verizon
VZ
$195B
$1.31M 1.12%
24,360
-10
-0% -$572

Similar funds

New England Research & Management's Q1 2020 Portfolio in Review

As of Q1 2020, New England Research & Management held 177 positions worth $117M, down 22% from $149M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

New England Research & Management withdrew a net $3.56M in Q1 2020, closing 44 positions and reducing 40 holdings. Its most notable exit was Clorox, an estimated $1.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, New England Research & Management opened a new position in Intercontinental Exchange worth $981K.

  • New England Research & Management's largest Q1 2020 buy was Intercontinental Exchange: 12,150 shares worth $981K.
  • New England Research & Management added most to Union Pacific in Q1 2020, an estimated $1.01M increase.
  • New England Research & Management's biggest Q1 2020 reduction was Gilead Sciences, cutting an estimated $1.2M.
  • New England Research & Management fully exited Clorox in Q1 2020, selling an estimated $1.3M.
  • New England Research & Management's ten largest holdings make up 27% of its $117M portfolio in Q1 2020.
  • New England Research & Management opened 26 new positions and closed 44 in Q1 2020.
  • New England Research & Management's portfolio value fell 22% quarter-over-quarter to $117M.

Based on New England Research & Management's 13F filing for Q1 2020, filed 15 Jun 2020.